SCHEMBL10123583

SCHEMBL10123583

COc1cc(NC(=O)NC(C)(C(F)(F)F)C(F)(F)F)cc(C)c1OC

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 3/20 0.60
CYP3A4 P08684 2/20 0.60
CYP2C9 P11712 2/20 0.60
MAPT P10636 3/20 0.49
GAA P10253 2/20 0.49
KDM4E B2RXH2 1/20 0.49
TP53 P04637 1/20 0.49
THRB P10828 1/20 0.49
RECQL P46063 1/20 0.49
PLEC Q15149 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
ALDH1A1 P00352 3/20 0.46
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
HTT P42858 2/20 0.43
POLB P06746 1/20 0.43
GFER P55789 1/20 0.43
PDK1 Q15118 1/20 0.41
PDK2 Q15119 1/20 0.41
PDK3 Q15120 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13993306 0.96 CYP2C19 (0.58) CYP2C19CYP3A4CYP2C9MAPTGAA
SCHEMBL422195 0.92 CYP3A4 (0.69) CYP2C19CYP3A4CYP2C9MAPTGAA
SCHEMBL29663729 0.73 MAPT (0.69) CYP2C19CYP3A4CYP2C9MAPTTP53
SCHEMBL419955 0.71 MAPT (0.52) CYP2C19CYP3A4CYP2C9MAPTGAA
SCHEMBL418319 0.70 PDK1 (0.65) MAPTGAAKDM4ETP53THRB
SCHEMBL420632 0.70 MAPT (0.67) MAPTGAAKDM4EL3MBTL1ALDH1A1
SCHEMBL420210 0.69 MAPT (0.76) MAPTGAAKDM4ETP53THRB
SCHEMBL19454815 0.69 ALDH1A1 (0.59) CYP2C19CYP3A4CYP2C9MAPTTP53
SCHEMBL10123508 0.69 MAPT (0.47) CYP2C19CYP3A4CYP2C9MAPTGAA
SCHEMBL10123473 0.68 PDK1 (0.62) MAPTGAATP53ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012060820-A1 SULFONYL SEMICARBAZIDES, SEMICARBAZIDES AND UREAS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS FOR TREATING HEMORRHAGIC FEVER VIRUSES, INCLUDING INFECTIONS ASSOCIATED WITH ARENAVIRUSES SIGA TECHNOLOGIES, INC. (US) 2012-05-10 WO disclosed